MRI appearance of femoral head osteonecrosis following core decompression and bone grafting

1991 ◽  
Vol 20 (2) ◽  
Author(s):  
TeresaW. Chan ◽  
MurrayK. Dalinka ◽  
MarvinE. Steinberg ◽  
HerbertY. Kressel
Keyword(s):  
Femoral Head ◽  
Bone Grafting ◽  
Core Decompression ◽  
Femoral Head Osteonecrosis

scholarly journals Hip-preserving surgical treatment for atraumatic femoral head necrosis

2020 ◽  
Vol 26 (4) ◽  
pp. 495-501
Author(s):  
A.E. Murzich ◽  
◽  
O.A. Sokolovsky ◽  
G.A. Uryev ◽  
◽  
...  
Keyword(s):  
Femoral Head ◽  
Minimally Invasive ◽  
Bone Grafting ◽  
Young Patients ◽  
Core Decompression ◽  
Autologous Bone Marrow ◽  
Femoral Head Necrosis ◽  
Long Term Results ◽  
Surgical Interventions ◽  
Femoral Head Osteonecrosis

Introduction Hip-salvage treatment in femoral head necrosis has a great social and economic importance.The number of hip joint replacements in young patients has been increasing. Purpose To evaluate the results of hip-preserving surgical interventions in the treatment of patients with non-traumatic femoral head necrosis. Materials and methods The study included 42 cases treated by minimally invasive core decompression of the femoral head and bone grafting, 22 cases of decompression and introduction of autologous bone marrow and mesenchymal stem cells into the core of necrosis, and six cases of using a titanium locking mesh implant. Results The follow-up time after surgery was up to 5 years. The survival rate of hip-reserving operations using cell technology to stimulate osteoregeneration were noticeably better than using bone grafting only in disease stages I, IIA, IIB, IIC. For femoral head osteonecrosis in stage IIIA, a titanium locking femoral head implant has been developed. It promotes regeneration and performs a supporting function. Conclusion The analysis of long-term results of these minimally invasive technologies has proven their efficacy and safety along with a low rate of complications.

Early Results of Core Decompression and Autologous Bone Marrow Mononuclear Cells Instillation in Femoral Head Osteonecrosis

2012 ◽  
Vol 27 (5) ◽  
pp. 679-686 ◽  
Author(s):  
Ramesh Kumar Sen ◽  
Sujit Kumar Tripathy ◽  
Sameer Aggarwal ◽  
Neelam Marwaha ◽  
Ratti Ram Sharma ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Femoral Head ◽  
Mononuclear Cells ◽  
Core Decompression ◽  
Autologous Bone Marrow ◽  
Bone Marrow Mononuclear Cells ◽  
Femoral Head Osteonecrosis ◽  
Early Results ◽  
Autologous Bone

Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis

2020 ◽  
pp. 1-8
Author(s):  
Filippo Migliorini ◽  
Nicola Maffulli ◽  
Jörg Eschweiler ◽  
Markus Tingart ◽  
Alice Baroncini
Keyword(s):  
Bone Marrow ◽  
Femoral Head ◽  
Core Decompression ◽  
Cell Therapies ◽  
Femoral Head Osteonecrosis

Physical Therapy Alone Compared with Core Decompression and Physical Therapy for Femoral Head Osteonecrosis in Sickle Cell Disease

2006 ◽  
Vol 88 (12) ◽  
pp. 2573-2582 ◽  
Author(s):  
Lynne D. Neumayr ◽  
Christine Aguilar ◽  
Ann N. Earles ◽  
Harry E. Jergesen ◽  
Charles M. Haberkern ◽  
...  
Keyword(s):  
Physical Therapy ◽  
Femoral Head ◽  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Core Decompression ◽  
Cell Disease ◽  
Femoral Head Osteonecrosis

scholarly journals High Failure Rate after Beta-tricalcium Phosphate Grafting for the Treatment of Femoral Head Osteonecrosis: a Retrospective Analysis

2020 ◽  
Author(s):  
Pei Liu ◽  
Xiao-hong Mu ◽  
Hua-chen Yu ◽  
Guan Jian-lei ◽  
Zhao-hui Liu ◽  
...  
Keyword(s):  
Femoral Head ◽  
Failure Rate ◽  
Tricalcium Phosphate ◽  
Bone Grafting ◽  
Harris Hip Score ◽  
Time To Failure ◽  
Light Bulb ◽  
High Failure Rate ◽  
Beta Tricalcium Phosphate ◽  
Femoral Head Osteonecrosis

Abstract Background: Non-vascularized bone grafting is a promising head-preserving technique for younger patients diagnosed as non-traumatic osteonecrosis of the femoral head (NONFH). Among the various types of bone grafting techniques, “light-bulb” procedure grafting with synthetic bone substitute is an attractive option. We aimed to assess the effectiveness of using beta-tricalcium phosphate (β-TCP) for the treatment of pre-collapse and early post-collapse lesions NONFH. Methods: From April 2010 to June 2014, 33 patients (47 hips) with NONFH were treated using the afore-mentioned technique. The clinical and radiological outcomes were recorded and compared statistically between pre- and post-operation. Harris hip score (HHS) was used to evaluate the clinical results, and Association Research Circulation Osseous (ARCO) stage was applied to assess the radiological outcomes. Results: The 5-years survival rate of using β-TCP grafting was accounting for 25.5%. HHS was decreased from 78.47 to 52.87 points, and a very significant worsening of radiological results were revealed ( P < 0.05). 2 hips collapsed more than 2 mm were awaiting for THA, and 33 of the 47 hips had converted to THAs in an average time to failure of 24.24 months postoperatively. Meanwhile, only 4 hips survived without collapse, and 8 hips collapsed less than 2 mm. After surgery, the time onset of head collapse was 3.65 months on average, and the first conversion to THA was performed at 5 months postoperative. Conclusions: Our results suggest that “light-bulb” procedure grafting with β-TCP sticks presented with a high failure rate in the early postoperative period. It is not proposed for the treatment of pre-collapse and early post-collapse lesions NONFH.

Sign in / Sign up

Export Citation Format

Share Document